Adamas to Present at Upcoming William Blair Biotech Focus Conference
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) announced that CEO Neil F. McFarlane will participate in a fireside chat at the William Blair Biotech Focus Conference 2021 on July 15, 2021, at 1:00 PM ET. This event, which will focus on the company's dedication to neurological disease treatments, will be broadcast live from the investor relations section of the Adamas website. Replays will be available for 30 days post-event. Adamas aims to deliver innovative therapies to alleviate the burden of neurological diseases.
- None.
- None.
Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a company dedicated to developing and delivering medicines that make a meaningful difference to people affected by neurological diseases, today announced that Neil F. McFarlane, Chief Executive Officer, will participate in a fireside chat at the William Blair Biotech Focus Conference 2021 on Thursday, July 15, 2021 at 1:00 pm Eastern Time.
The fireside chat will be broadcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Replays of the event will be available for 30 days.
About Adamas Pharmaceuticals, Inc.
At Adamas our vision is clear – to deliver innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. We are a fully-integrated company focused on growing a portfolio of therapies to address a range of neurological diseases. For more information, please visit www.adamaspharma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005682/en/
FAQ
What is the date and time of the Adamas Pharmaceuticals fireside chat?
Where can I watch the Adamas Pharmaceuticals fireside chat?
How long will the replay of the Adamas Pharmaceuticals event be available?
Who is the CEO of Adamas Pharmaceuticals participating in the conference?
What is the focus of Adamas Pharmaceuticals during the conference?
